glp-1 small molecule Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor Structural insights into the activation

Do you take insurance

This story mentions GLP-1 drugs, which are FDA-approved for weight management in adults diagnosed with obesity or with overweight and at least one weight-related health condition

Helicobacter pylori

For Canadians exploring surgical and non-surgical weight management pathways, this related guide provides helpful context: The Ultimate Guide to Weight Loss Surgery in Canada Understanding all available options helps Canadians make informed decisions with their care teams

13.5% of participants in the semaglutide group discontinued their treatment due to side effects, compared to 27.6% with liraglutide

What They Do GLP-1 receptor agonists (e.g., semaglutide, liraglutide